1-2 of 2
Adele Fielding, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In Adults with Standard-Risk Acute Lymphoblastic Leukemia (ALL) the Greatest Benefit Is Achieved from an Allogeneic Transplant in First Complete Remission (CR) and an Autologous Transplant Is Less Effective Than Conventional Consolidation/Maintenance Chemotherapy: Final Results of the International ALL Trial (MRC UKALL XII/ECOG E2993).

Jacob M. Rowe, MD, Georgina Buck, PhD, Adele Fielding, MD, Martin S. Tallman, MD, Alan K. Burnett, MD, Raj Chopra, MD, Peter H. Wiernik, MD, Susan M. Richards, PhD, Hillard M. Lazarus, MD, Letizia Foroni, MD, Elisabeth Paietta, PhD, Mark R. Litzow, MD, David Marks, MD, Jill Durrant, MD, Anthony H. Goldstone, MD
Journal: Blood
Blood (2006) 108 (11): 2.
https://doi.org/10.1182/blood.V108.11.2.2
Published: 2006
Journal Articles

Value of Molecular Monitoring for Minimal Residual Disease Preceding Autologous SCT Following Diagnosis of B Cell Acute Lymphoblastic Leukemia in Patients Treated with the MRC UKALL12 Protocol.

Letizia Foroni, MD, PhD, Wayne Mitchell, PhD, Lena J. Rai, Anouska Casanova, Bella Patel, MD, Sue Richards, Adele Fielding, MD, Anthony H. Goldstone
Journal: Blood
Blood (2005) 106 (11): 1468.
https://doi.org/10.1182/blood.V106.11.1468.1468
Published: 2005